Yusop, Mia .

HRN: 15-52-20  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2023
CEFTRIAXONE 1G (VIAL)
10/18/2023
10/25/2023
IV
2g
OD
UTI
Checking Final Appropriateness 
10/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/18/2023
10/25/2023
IV
600mg
Q6hr
Nonhealing Wound
Checking Final Appropriateness 
10/25/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/25/2023
11/01/2023
IV
600mg
Q8
Infected Wound
Checking Final Appropriateness 
10/26/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
10/26/2023
10/26/2023
TOPICAL
1%
BID
Infected Wound, Right
Waiting Final Action 
07/13/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/13/2024
07/20/2024
IV
1.5g
Q6hours
Infected Wound Left Foot
Waiting Final Action 
07/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/13/2024
07/20/2024
IV
600mg
Q 6 Hours
Non- Healing Wound
Waiting Final Action 
07/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/14/2024
07/21/2024
IV DRIP
4.5g
Q8
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: